
Zencore Biologics
Shanghai, China zencorebio.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Zencore Biologics is an independent biologics CDMO headquartered in Lin-gang Special Area, Shanghai, China. It provides end-to-end services from cell line development and process development through GMP manufacturing, analytical support, and regulatory filing support for biopharmaceutical companies. It also has operations in the United States through its US Innovation Center in Germantown, Maryland.
Services
Research services
Developability assessment, cell line development, early pharmaceutical research, and project feasibility evaluation.
Development services
Process development and scale-up, analytical method development and validation, and pilot manufacturing for non-GMP/GMP work.
Manufacturing services
Drug substance manufacturing, drug product filling, and global GMP supply.
CDMO: development & manufacturing
Quality & regulatory
Global CMC regulatory filings, quality management and compliance, and regulatory strategy support.
Biologics CDMO
Integrated biologics CDMO services from developability assessment to commercial manufacturing.
CDMO: development & manufacturing
ADC CDMO
End-to-end ADC development and manufacturing from proof of concept to commercialization.
CDMO: development & manufacturing
Cell culture media services
Custom media development, pilot manufacturing, catalog media, and GMP commercial manufacturing.
Protein production
Analytical services
Biologics analysis and quality research from sequence to BLA, including release characterization and stability testing.
- Turnaround
- Delivery within one month
- What to send
- Project sample delivery
Capabilities
- Assays and studies
- ADCs
- Antibodies
- Process development
- Bioreactors
- Analytical development
- Stability studies
11 more
- Release characterization
- Impurity identification
- Similarity assessment
- AUC
- High-resolution mass spectrometry
- Sequence analysis
- Developability assessment
- Method development and validation
- Batch-to-batch consistency
- Biosimilarity assessment
- Cell line CQA testing
- Scale and capacity
- 25,000 L total capacity
- 90,500 L planned capacity
- 3×2,000 L single-use production lines
- 3×5,000 L stainless-steel production lines
- 4×200 L single-use bioreactors
- 3×500 L single-use bioreactors
5 more
- 1×500 L GMP pilot bioreactor
- 2×200 L GMP pilot bioreactors
- 200 tonnes/year annual media capacity
- 10M+10M vials + prefilled syringes/year
- 24,000 vials/hour
Instruments and platforms
- AUC analytical ultracentrifugation
- Q-TOF Waters high-resolution mass spectrometer
- QE Thermo high-resolution mass spectrometer
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Peptide
- Species and models
- CHO-K1
- CHO-DG44
- CHO-S
- CHOZN
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
ISO 13485Self-reported
Scope: media manufacturing systems
Details
- Type
- CRDMO
- Founded
- 2017
- Office
- 289 Zhengjia Road
- Sites
- Germantown, Maryland, USA
- Serves
- Global
Public records
- FDA drug establishment registration
- 3025687970 · ANALYSIS; MANUFACTURE source